You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Obinutuzumab

Showing 151 - 175 of 229
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) Trial in United States (Obinutuzumab, Bendamustine,

Active, not recruiting
  • Chronic Lymphocytic Leukemia (CLL)
  • Small Lymphocytic Lymphoma (SLL)
  • Obinutuzumab
  • +2 more
  • Tempe, Arizona
  • +14 more
Jan 12, 2022

Chronic Lymphocytic Leukemia Trial in France, Germany, United States (Bendamustine, Obinutuzumab, Rituximab)

Completed
  • Chronic Lymphocytic Leukemia
  • La Jolla, California
  • +11 more
Oct 12, 2020

Part1: Advanced B-cell Malignancies, Part2: r/rCLL and r/rMCL, Part3: Untreated CLL Trial in Japan (Acalabrutinib, Obinutuzumab)

Active, not recruiting
  • Part1: Advanced B-cell Malignancies
  • +2 more
  • Chiba-shi, Japan
  • +13 more
Jan 31, 2022

Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in

Completed
  • Chronic Lymphocytic Leukemia
  • Obinutuzumab
  • Buenos Aires, Argentina
  • +2 more
Apr 16, 2020

Chronic Lymphocytic Leukemia Trial in Worldwide (Acalabrutinib, Venetoclax, Chemoimmunotherapy)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Fountain Valley, California
  • +201 more
Jan 16, 2023

Relapsed Follicular Lymphoma, Refractory Follicular Lymphoma Trial in United Kingdom (Epcoritamab, Lenalidomide, Rituximab)

Not yet recruiting
  • Relapsed Follicular Lymphoma
  • Refractory Follicular Lymphoma
  • Aberdeen, United Kingdom
  • +24 more
Apr 28, 2023

Chronic Lymphocytic Leukemia Trial in Worldwide (Fludarabine, Cyclophosphamide, Rituximab)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Wien, Austria
  • +160 more
Sep 29, 2021

Grade 1 Follicular Lymphoma, Grade 2 Follicular Lymphoma, Grade 3a Follicular Lymphoma Trial in United States (Bendamustine

Suspended
  • Grade 1 Follicular Lymphoma
  • +4 more
  • Bendamustine Hydrochloride
  • +13 more
  • Anchorage, Alaska
  • +422 more
Feb 2, 2023

Lymphoma Trial in Worldwide (CC-220, Rituximab, Obinutuzumab)

Recruiting
  • Lymphoma
  • Phoenix, Arizona
  • +36 more
Jul 28, 2022

Chronic Lymphocytic Leukemia Trial in Worldwide (Obinutuzumab, Ublituximab, TGR-1202)

Active, not recruiting
  • Chronic Lymphocytic Leukemia
  • Obinutuzumab
  • +3 more
  • Huntsville, Alabama
  • +153 more
Aug 19, 2022

Non-Hodgkin's Lymphoma Trial in Worldwide (Idasanutlin, Obinutuzumab, Rituximab)

Terminated
Has Results
  • Non-Hodgkin's Lymphoma
  • Phoenix, Arizona
  • +23 more
Apr 29, 2020

Chronic Lymphocytic Leukemia, Small-Cell Lymphoma Trial in Worldwide (Ibrutinib, Obinutuzumab, Chlorambucil)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Small-Cell Lymphoma
  • La Jolla, California
  • +70 more
Aug 27, 2020

Mantle Cell Lymphoma Trial in France, United Kingdom (Ibrutinib + GA101 +GDC-0199)

Active, not recruiting
  • Mantle Cell Lymphoma
  • Ibrutinib + GA101 +GDC-0199
  • Angers, France
  • +8 more
Mar 11, 2020

Chronic Lymphoid Leukemia Trial in Worldwide (Ibrutinib, Venetoclax, Obinutuzumab)

Recruiting
  • Chronic Lymphoid Leukemia
  • Ibrutinib
  • +2 more
  • Graz, Austria
  • +180 more
Jan 21, 2022

Kidney Failure, Chronic Trial in United States (Obinutuzumab, Intravenous Immunoglobulin)

Completed
  • Kidney Failure, Chronic
  • Obinutuzumab
  • Intravenous Immunoglobulin
  • Los Angeles, California
  • +8 more
Jan 27, 2020

Lymphoma Trial in Worldwide (Atezolizumab, Obinutuzumab, Tazemetostat)

Completed
  • Lymphoma
  • Duarte, California
  • +14 more
Jan 22, 2020

Lymphoma, Non Hodgkin Trial in France, United States (Cyclophosphamide, Doxorubicin, Obinutuzumab)

Completed
Has Results
  • Lymphoma, Non Hodgkin
  • Birmingham, Alabama
  • +10 more
Feb 18, 2020

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma Trial in Canada, United States (biological, other, drug)

Recruiting
  • Chronic Lymphocytic Leukemia
  • Small Lymphocytic Lymphoma
  • Obinutuzumab
  • +3 more
  • Birmingham, Alabama
  • +484 more
Aug 24, 2022

Solid Tumors Trial in Worldwide (RO7172508, Obinutuzumab, Tocilizumab)

Terminated
Has Results
  • Solid Tumors
  • Bruxelles, Belgium
  • +5 more
Aug 17, 2020

Chronic Lymphocytic Leukemia Trial in Huntsville, Memphis (TGR-1202 + Obinutuzumab + Chlorambucil)

Completed
  • Chronic Lymphocytic Leukemia
  • TGR-1202 + Obinutuzumab + Chlorambucil
  • Huntsville, Alabama
  • +1 more
Oct 1, 2019

Lymphocytic Leukemia, Chronic Trial in United Kingdom, United States (Obinutuzumab, Venetoclax)

Completed
  • Lymphocytic Leukemia, Chronic
  • La Jolla, California
  • +9 more
Jan 7, 2020

Follicular Lymphoma, Mantle Cell Lymphoma Trial in Rouen (Determination of COVID-19 vacciantion efficacy)

Completed
  • Follicular Lymphoma
  • Mantle Cell Lymphoma
  • Determination of COVID-19 vacciantion efficacy
  • Rouen, France
    Centre Henri Becquerel
Dec 22, 2022

Chronic Lymphocytic Leukemia Trial in Spain (bendamustine, obinutuzumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Vitoria, Alava, Spain
  • +20 more
Feb 5, 2020

Chronic Lymphocytic Leukemia Trial in Hwasun (Obinutuzumab)

Unknown status
  • Chronic Lymphocytic Leukemia
  • Obinutuzumab
  • Hwasun, Jeollanam-do, Korea, Republic of
    Chonnam National University Hwasun Hospital
Aug 15, 2019

Chronic Lymphocytic Leukemia Trial in United States (Bendamustine, Obinutuzumab)

Completed
Has Results
  • Chronic Lymphocytic Leukemia
  • Huntsville, Alabama
  • +25 more
Feb 3, 2020